Effect of the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae in the first 2 years of life

被引:137
作者
Ghaffar, F
Barton, T
Lozano, J
Muniz, LS
Hicks, P
Gan, V
Ahmad, N
McCracken, GH
机构
[1] Univ Texas, SW Med Ctr, Dept Pediat, Div Infect Dis, Dallas, TX 75235 USA
[2] Childrens Med Ctr, Continu Care Clin, Dallas, TX 75235 USA
关键词
D O I
10.1086/423379
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Studies suggest that the 7- valent pneumococcal conjugate vaccine ( PCV7) reduces carriage of vaccine- type ( VT) Streptococcus pneumoniae ( SP). We studied the effect of PCV7 on carriage of VT- and non- VT ( NVT) SP, by studying the effect of PCV7 on nasopharyngeal ( NP) colonization by VT and NVT SP during early childhood. Methods. At 2 months of age, 278 infants were enrolled in this study. To determine carriage of SP, NP samples were obtained before each PCV7 dose, at 9 months of age, and 2 - 3 months after the booster dose of vaccine. Results. The carriage of SP increased slightly, from 12% ( 95% confidence interval [ CI], 8% - 16%) of subjects at 2 months of age to 18% ( 95% CI, 13% - 23%) at 4 months of age (P <.05). Carriage of SP remained in 24% - 30% of subjects during subsequent months. Between the 12- and 18- month visits, the carriage rate of VT SP decreased significantly, from 18% ( 95% CI, 13% - 23%) to 9% ( 95% CI, 5% - 13%) of subjects (P = .001). The trend of a decrease in carriage of penicillin- nonsusceptible SP, from 16% of subjects ( 95% CI, 11% - 21%) at the 12 - 15- month visit to 9% ( 95% CI, 5% - 13%) at the 15 - 18- month visit, was found after the booster dose of vaccine. Conclusion. The reduction of VT- SP colonization and replacement by NVT SP after the booster dose of vaccine suggests the possibility that widespread vaccination will result in replacement of pneumococci mainly by antibiotic- susceptible NVT SP.
引用
收藏
页码:930 / 938
页数:9
相关论文
共 32 条
[1]   Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants [J].
Ahman, H ;
Kayhty, H ;
Tamminen, P ;
Vuorela, A ;
Malinoski, F ;
Eskola, J .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1996, 15 (02) :134-139
[2]  
AUSTRIAN R, 1976, MT SINAI J MED, V43, P699
[3]   THE IMPACT OF CONJUGATE VACCINE ON CARRIAGE OF HAEMOPHILUS-INFLUENZAE TYPE-B [J].
BARBOUR, ML ;
MAYONWHITE, RT ;
COLES, C ;
CROOK, DWM ;
MOXON, ER .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (01) :93-98
[4]   Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children [J].
Black, S ;
Shinefield, H ;
Fireman, B ;
Lewis, E ;
Ray, P ;
Hansen, JR ;
Elvin, L ;
Ensor, KM ;
Hackell, J ;
Siber, G ;
Malinoski, F ;
Madore, D ;
Chang, I ;
Kohberger, R ;
Watson, W ;
Austrian, R ;
Edwards, K .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (03) :187-195
[5]   Primary and booster salivary antibody responses to a 7-valent pneumococcal conjugate vaccine in infants [J].
Choo, S ;
Zhang, QB ;
Seymour, L ;
Akhtar, S ;
Finn, A .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (04) :1260-1263
[6]   Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers [J].
Dagan, R ;
Givon-Lavi, N ;
Zamir, O ;
Fraser, D .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (06) :532-539
[7]   Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers [J].
Dagan, R ;
Givon-Lavi, N ;
Zamir, O ;
Sikuler-Cohen, M ;
Guy, L ;
Janco, J ;
Yagupsky, P ;
Fraser, D .
JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (07) :927-936
[8]   Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid [J].
Dagan, R ;
Muallem, M ;
Melamed, R ;
Leroy, O ;
Yagupsky, P .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1997, 16 (11) :1060-1064
[9]   Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine [J].
Dagan, R ;
Melamed, R ;
Muallem, M ;
Piglansky, L ;
Greenberg, D ;
Abramson, O ;
Mendelman, PM ;
Bohidar, N ;
Yagupsky, P .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (06) :1271-1278
[10]  
EDWARDS KM, 1999, 37 ANN M INF DIS SOC, P966